Epigenetic aspects in carcinomas of the head and neck;Epigenetische Aspekte bei Karzinomen der Kopf-Hals-Region

HNO

Volumn 56, Issue 6, 2008, Pages 594-602

  Schmezer, P ^a   Plass, C ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biomarker; DNA methylation; Epigenetics; HNSCC; Promoter hypermethylation

Indexed keywords

TUMOR MARKER;

ARTICLE; BIOLOGICAL MODEL; DNA METHYLATION; GENETIC EPIGENESIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; HUMAN; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 45249100682     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-008-1720-3     Document Type: Article

References (109)

1. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945
2. Aarstad HJ, Aarstad AK, Birkhaug EJ et al. (2003) The personality and quality of life in HNSCC patients following treatment. Eur J Cancer 39: 1852-1860
3. Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132: 4653-4662
4. Barreto G, Schafer A, Marhold J et al. (2007) Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671-675
5. Beder LB, Gunduz M, Ouchida M et al. (2003) Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 83: 99-105
6. Bennett KL, Hackanson B, Smith LT et al. (2007) Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res 67: 4657-4664
7. Bestor TH, Verdine GL (1994) DNA methyltransferases. Curr Opin Cell Biol 6: 380-389
8. Bird A, Taggart M, Frommer M et al. (1985) A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40: 91-99
9. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213
10. Birkhaug EJ, Aarstad HJ, Aarstad AK et al. (2002) Relation between mood, social support and the quality of life in patients with laryngectomies. Eur Arch Otorhinolaryngol 259: 197-204
11. Blot WJ, Mclaughlin JK, Winn DM et al. (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48: 3282-3287
12. Bockmuhl U, Wolf G, Schmidt S et al. (1998) Genomic alterations associated with malignancy in head and neck cancer. Head Neck 20: 145-151
13. Boring CC, Squires TS, Tong T (1991) Cancer statistics, 1991. Bol Asoc Med P R 83: 225-242
14. Brena RM, Huang TH, Plass C (2006) Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings. J Mol Med 84: 1-13
15. Brennecke J, Stark A, Russell RB et al. (2005) Principles of microRNA-target recognition. PLoS Biol 3: e85
16. Cabelguenne A, Loriot MA, Stucker I et al. (2001) Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer 93: 725-730
17. Cai WW, Mao JH, Chow CW et al. (2002) Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 20: 393-396
18. Califano J, Van Der Riet P, Westra W et al. (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492
19. Calin GA, Ferracin M, Cimmino A et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801
20. Carvalho AL, Chuang A, Jiang WW et al. (2006) Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res 66: 9401-9407
21. Carvalho AL, Jeronimo C, Kim MM et al. (2008) Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 14: 97-107
22. Chen CZ (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771
23. Clark SJ, Harrison J, Paul CL et al. (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997
24. Colella S, Shen L, Baggerly KA et al. (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150
25. Coon SW, Savera AT, Zarbo RJ et al. (2004) Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int J Cancer 111: 206-212
26. Costello JF, Fruhwald MC, Smiraglia DJ et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24: 132-138
27. Cummins JM, He Y, Leary RJ et al. (2006) The colorectal microRNAome. Proc Natl Acad Sci U S A 103: 3687-3692
28. Dikshit RP, Gillio-Tos A, Brennan P et al. (2007) Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110: 1745-1751
29. Dong SM, Sun DI, Benoit NE et al. (2003) Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 9: 3635-3640
30. Dos Reis PP, Poli-Frederico RC, Dos Santos RM et al. (2002) Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit 8: BR89-BR94
31. Eckhardt F, Lewin J, Cortese R et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38: 1378-1385
32. Eder M, Scherr M (2005) MicroRNA and lung cancer. N Engl J Med 352: 2446-2448
33. Ehrich M, Nelson MR, Stanssens P et al. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A 102: 15785-15790
34. Ehrlich M (2000) DNA hypomethylation and cancer. In: Ehrlich M (ed) DNA alterations in cancer. Eaton Publishing, Natick, MA, pp 273-291
35. El-Naggar AK, Lai S, Clayman G et al. (1997) Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 151: 1767-1774
36. Estecio MR, Youssef EM, Rahal P et al. (2006) LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene 25: 5018-5026
37. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298
38. Esteller M, Hamilton SR, Burger PC et al. (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797
39. Ferlay A, Martin B, Pradel P et al. (2006) Influence of grass-based diets on milk fatty acid composition and milk lipolytic system in Tarentaise and Montbeliarde cow breeds. J Dairy Sci 89: 4026-4041
40. Forozan F, Karhu R, Kononen J et al. (1997) Genome screening by comparative genomic hybridization. Trends Genet 13: 405-409
41. Franzmann EJ, Reategui EP, Pedroso F et al. (2007) Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16: 1348-1355
42. Freitas MA, Sklenar AR, Parthun MR (2004) Application of mass spectrometry to the identification and quantification of histone post-translational modifications. J Cell Biochem 92: 691-700
43. Frigola J, Ribas M, Risques RA et al. (2002) Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res 30: e28
44. Gifford G, Paul J, Vasey PA et al. (2004) The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients. Clin Cancer Res 10: 4420-4426
45. Gonzalez MV, Pello MF, Ablanedo P et al. (1998) Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck. J Clin Pathol 51: 520-524
46. Gonzalez MV, Pello MF, Lopez-Larrea C et al. (1997) Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J Clin Pathol 50: 509-512
47. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70
48. Hart TC (1997) Applications of molecular epidemiology to head and neck cancer. Otolaryngol Clin North Am 30: 21-34
49. Hasegawa M, Nelson HH, Peters E et al. (2002) Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21: 4231-4236
50. Hashimoto Y, Oga A, Kawauchi S et al. (2001) Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 129: 52-56
51. Hatada I, Hayashizaki Y, Hirotsune S et al. (1991) A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci U S A 88: 9523-9527
52. He H, Jazdzewski K, Li W et al. (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102: 19075-19080
53. Hebert C, Norris K, Scheper MA et al. (2007) High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6: 5
54. Herman JG, Graff JR, Myohanen S et al. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-9826
55. Herman JG, Merlo A, Mao L et al. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530
56. Hoa M, Davis SL, Ames SJ et al. (2002) Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma. Cancer Res 62: 7154-7156
57. Hogg RP, Honorio S, Martinez A et al. (2002) Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer 38: 1585-1592
58. Jemal A, Murray T, Ward E et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10-30
59. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074-1080
60. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428
61. Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22: 165-173
62. Kraunz KS, Hsiung D, Mcclean MD et al. (2006) Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma. Int J Cancer 119: 1553-1557
63. Leemans CR, Tiwari R, Nauta JJ et al. (1994) Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73: 187-190
64. Li E (2002) Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 3: 662-673
65. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926
66. Lin M, Smith LT, Smiraglia DJ et al. (2006) DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25: 1424-1433
67. Lu J, Getz G, Miska EA et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838
68. Marsit CJ, Houseman EA, Christensen BC et al. (2006) Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res 66: 10621-10629
69. Marsit CJ, Liu M, Nelson HH et al. (2004) Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 23: 1000-1004
70. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838-849
71. Martone T, Gillio-Tos A, De Marco L et al. (2007) Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res 13: 5089-5094
72. Masuda M, Suzui M, Yasumatu R et al. (2002) Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62: 3351-3355
73. Meltzer PS (2005) Cancer genomics: small RNAs with big impacts. Nature 435: 745-746
74. Nayak CS, Carvalho AL, Jeronimo C et al. (2007) Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Laryngoscope 117: 1376-1380
75. Ng HH, Bird A (1999) DNA methylation and chromatin modification. Curr Opin Genet Dev 9: 158-163
76. Okano M, Bell DW, Haber DA et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257
77. Oude Ophuis MB, Manni JJ, Peters WH (2006) Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer. Acta Otolaryngol 126: 311-317
78. Patel AM, Incognito LS, Schechter GL et al. (1996) Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 12: 31-35
79. Pillai RS (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11: 1753-1761
80. Rakyan VK, Hildmann T, Novik KL et al. (2004) DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol 2: e405
81. Rauch T, Pfeifer GP (2005) Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab Invest 85: 1172-1180
82. Rehwinkel J, Behm-Ansmant I, Gatfield D et al. (2005) A crucial role for GW182 and the DCP1: DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11: 1640-1647
83. Righini CA, De Fraipont F, Timsit JF et al. (2007) Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 13: 1179-1185
84. Robertson K, Keymarsi K, Gonzales F et al. (2000) Differential mRNA expression of the human DNA methyltransferase (DNMTs)1, 3a and 3b during the Go/G1 to S phase transition in normal and tumor cells. Nucleic Acids Res 28: 2108-2113
85. Rosas SL, Koch W, Da Costa Carvalho MG et al. (2001) Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61: 939-942
86. Rountree MR, Bachman KE, Baylin SB (2000) DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25: 269-277
87. Saito Y, Liang G, Egger G et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443
88. Santos-Rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41: 2381-2402
89. Sengupta S, Chakrabarti S, Roy A et al. (2007) Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 109: 703-712
90. Shen L, Catalano PJ, Benson AB 3rd et al. (2007) Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13: 6093-6098
91. Singh B, Stoffel A, Gogineni S et al. (2002) Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 161: 365-371
92. Singh M, Shah PP, Singh AP et al. (2008) Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638: 184-194
93. Smiraglia DJ, Fruhwald MC, Costello JF et al. (1999) A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics 58: 254-262
94. Smiraglia DJ, Plass C (2002) The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 21: 5414-5426
95. Smiraglia DJ, Smith LT, Lang JC et al. (2003) Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet 40: 25-33
96. Smith LT, Lin M, Brena RM et al. (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci U S A 103: 982-987
97. Suzuki H, Gabrielson E, Chen W et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149
98. Takebayashi S, Hickson A, Ogawa T et al. (2004) Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 41: 145-154
99. Tan D, Wiseman S, Zhou Y et al. (2004) Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique. Diagn Mol Pathol 13: 33-40
100. Taylor KH, Kramer RS, Davis JW et al. (2007) Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 67: 8511-8518
101. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934
102. Vokes EE, Weichselbaum RR, Lippman SM et al. (1993) Head and neck cancer. N Engl J Med 328: 184-194
103. Waber P, Dlugosz S, Cheng QC et al. (1997) Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a. Oncogene 15: 1699-1704
104. Weber A, Hengge UR, Bardenheuer W et al. (2005) SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24: 6699-6708
105. Weber M, Davies JJ, Wittig D et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862
106. Winn DM, Blot WJ, Mclaughlin JK et al. (1991) Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 51: 3044-3047
107. Woenckhaus J, Steger K, Werner E et al. (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198: 335-342
108. Xiong Z, Laird PW (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534
109. Yan PS, Wei SH, Huang TH (2002) Differential methylation hybridization using CpG island arrays. Methods Mol Biol 200: 87-100